List of Tables
Table 1. Global Boron-containing Compounds Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Boron-containing Compounds Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Boron-containing Compounds Drug Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Boron-containing Compounds Drug Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Boron-containing Compounds Drug Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Boron-containing Compounds Drug Sales by Region (2020-2025) & (Units)
Table 8. Global Boron-containing Compounds Drug Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Boron-containing Compounds Drug Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Boron-containing Compounds Drug Sales Share by Manufacturers (2020-2025)
Table 12. Global Boron-containing Compounds Drug Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Boron-containing Compounds Drug Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Boron-containing Compounds Drug by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Boron-containing Compounds Drug as of 2024)
Table 16. Global Boron-containing Compounds Drug Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Boron-containing Compounds Drug Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Boron-containing Compounds Drug Manufacturing Base and Headquarters
Table 19. Global Boron-containing Compounds Drug Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Boron-containing Compounds Drug Sales by Type (2020-2025) & (Units)
Table 23. Global Boron-containing Compounds Drug Sales by Type (2026-2031) & (Units)
Table 24. Global Boron-containing Compounds Drug Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Boron-containing Compounds Drug Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Boron-containing Compounds Drug ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Boron-containing Compounds Drug Sales by Application (2020-2025) & (Units)
Table 29. Global Boron-containing Compounds Drug Sales by Application (2026-2031) & (Units)
Table 30. Boron-containing Compounds Drug High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Boron-containing Compounds Drug Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Boron-containing Compounds Drug Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Boron-containing Compounds Drug ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Boron-containing Compounds Drug Growth Accelerators and Market Barriers
Table 37. North America Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Boron-containing Compounds Drug Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Boron-containing Compounds Drug Growth Accelerators and Market Barriers
Table 40. Europe Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Boron-containing Compounds Drug Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Boron-containing Compounds Drug Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Boron-containing Compounds Drug Growth Accelerators and Market Barriers
Table 45. Southeast Asia Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Boron-containing Compounds Drug Investment Opportunities and Key Challenges
Table 47. Central and South America Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Boron-containing Compounds Drug Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Boron-containing Compounds Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Takeda Pharmaceutical Corporation Information
Table 51. Takeda Pharmaceutical Description and Major Businesses
Table 52. Takeda Pharmaceutical Product Models, Descriptions and Specifications
Table 53. Takeda Pharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Takeda Pharmaceutical Sales Value Proportion by Product in 2024
Table 55. Takeda Pharmaceutical Sales Value Proportion by Application in 2024
Table 56. Takeda Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 57. Takeda Pharmaceutical Boron-containing Compounds Drug SWOT Analysis
Table 58. Takeda Pharmaceutical Recent Developments
Table 59. Janssen Pharmaceuticals Corporation Information
Table 60. Janssen Pharmaceuticals Description and Major Businesses
Table 61. Janssen Pharmaceuticals Product Models, Descriptions and Specifications
Table 62. Janssen Pharmaceuticals Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Janssen Pharmaceuticals Sales Value Proportion by Product in 2024
Table 64. Janssen Pharmaceuticals Sales Value Proportion by Application in 2024
Table 65. Janssen Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 66. Janssen Pharmaceuticals Boron-containing Compounds Drug SWOT Analysis
Table 67. Janssen Pharmaceuticals Recent Developments
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Major Businesses
Table 70. Pfizer Product Models, Descriptions and Specifications
Table 71. Pfizer Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Pfizer Sales Value Proportion by Product in 2024
Table 73. Pfizer Sales Value Proportion by Application in 2024
Table 74. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 75. Pfizer Boron-containing Compounds Drug SWOT Analysis
Table 76. Pfizer Recent Developments
Table 77. Hovione FarmaCiencia Corporation Information
Table 78. Hovione FarmaCiencia Description and Major Businesses
Table 79. Hovione FarmaCiencia Product Models, Descriptions and Specifications
Table 80. Hovione FarmaCiencia Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Hovione FarmaCiencia Sales Value Proportion by Product in 2024
Table 82. Hovione FarmaCiencia Sales Value Proportion by Application in 2024
Table 83. Hovione FarmaCiencia Sales Value Proportion by Geographic Area in 2024
Table 84. Hovione FarmaCiencia Boron-containing Compounds Drug SWOT Analysis
Table 85. Hovione FarmaCiencia Recent Developments
Table 86. Melinta Therapeutics Corporation Information
Table 87. Melinta Therapeutics Description and Major Businesses
Table 88. Melinta Therapeutics Product Models, Descriptions and Specifications
Table 89. Melinta Therapeutics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Melinta Therapeutics Sales Value Proportion by Product in 2024
Table 91. Melinta Therapeutics Sales Value Proportion by Application in 2024
Table 92. Melinta Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 93. Melinta Therapeutics Boron-containing Compounds Drug SWOT Analysis
Table 94. Melinta Therapeutics Recent Developments
Table 95. DC PHARMA Corporation Information
Table 96. DC PHARMA Description and Major Businesses
Table 97. DC PHARMA Product Models, Descriptions and Specifications
Table 98. DC PHARMA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. DC PHARMA Recent Developments
Table 100. Gao Jin Biology Corporation Information
Table 101. Gao Jin Biology Description and Major Businesses
Table 102. Gao Jin Biology Product Models, Descriptions and Specifications
Table 103. Gao Jin Biology Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Gao Jin Biology Recent Developments
Table 105. Neuboron Corporation Information
Table 106. Neuboron Description and Major Businesses
Table 107. Neuboron Product Models, Descriptions and Specifications
Table 108. Neuboron Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Neuboron Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Boron-containing Compounds Drug Product Picture
Figure 2. Global Boron-containing Compounds Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bortezomib Product Picture
Figure 4. Tavaborole Product Picture
Figure 5. Crisaborole Product Picture
Figure 6. Vaborbactam-Meropenem Product Picture
Figure 7. Ixazomib Product Picture
Figure 8. Others Product Picture
Figure 9. Global Boron-containing Compounds Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Multiple Myeloma
Figure 11. Toenail Fungal Infection
Figure 12. Atopic Dermatitis
Figure 13. Others
Figure 14. Boron-containing Compounds Drug Report Years Considered
Figure 15. Global Boron-containing Compounds Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 17. Global Boron-containing Compounds Drug Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Boron-containing Compounds Drug Revenue Market Share by Region (2020-2031)
Figure 19. Global Boron-containing Compounds Drug Sales (2020-2031) & (Units)
Figure 20. Global Boron-containing Compounds Drug Sales (CAGR) by Region (2020-2031) (Units)
Figure 21. Global Boron-containing Compounds Drug Sales Market Share by Region (2020-2031)
Figure 22. Top 5 and Top 10 Manufacturers Boron-containing Compounds Drug Sales Volume Market Share in 2024
Figure 23. Global Boron-containing Compounds Drug Revenue Market Share Ranking (2024)
Figure 24. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 25. Bortezomib Revenue Market Share by Manufacturer in 2024
Figure 26. Tavaborole Revenue Market Share by Manufacturer in 2024
Figure 27. Crisaborole Revenue Market Share by Manufacturer in 2024
Figure 28. Vaborbactam-Meropenem Revenue Market Share by Manufacturer in 2024
Figure 29. Ixazomib Revenue Market Share by Manufacturer in 2024
Figure 30. Others Revenue Market Share by Manufacturer in 2024
Figure 31. Global Boron-containing Compounds Drug Sales Market Share by Type (2020-2031)
Figure 32. Global Boron-containing Compounds Drug Revenue Market Share by Type (2020-2031)
Figure 33. Global Boron-containing Compounds Drug Sales Market Share by Application (2020-2031)
Figure 34. Global Boron-containing Compounds Drug Revenue Market Share by Application (2020-2031)
Figure 35. North America Boron-containing Compounds Drug Sales YoY (2020-2031) & (Units)
Figure 36. North America Boron-containing Compounds Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Boron-containing Compounds Drug Sales Revenue (US$ Million) in 2024
Figure 38. North America Boron-containing Compounds Drug Sales Volume (Units) by Type (2020- 2031)
Figure 39. North America Boron-containing Compounds Drug Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Boron-containing Compounds Drug Sales Volume (Units) by Application (2020-2031)
Figure 41. North America Boron-containing Compounds Drug Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Boron-containing Compounds Drug Sales YoY (2020-2031) & (Units)
Figure 46. Europe Boron-containing Compounds Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Boron-containing Compounds Drug Sales Revenue (US$ Million) in 2024
Figure 48. Europe Boron-containing Compounds Drug Sales Volume (Units) by Type (2020-2031)
Figure 49. Europe Boron-containing Compounds Drug Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Boron-containing Compounds Drug Sales Volume (Units) by Application (2020-2031)
Figure 51. Europe Boron-containing Compounds Drug Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 53. France Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Boron-containing Compounds Drug Sales YoY (2020-2031) & (Units)
Figure 58. Asia-Pacific Boron-containing Compounds Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Boron-containing Compounds Drug Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Boron-containing Compounds Drug Sales Volume (Units) by Type (2020- 2031)
Figure 61. Asia-Pacific Boron-containing Compounds Drug Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Boron-containing Compounds Drug Sales Volume (Units) by Application (2020-2031)
Figure 63. Asia-Pacific Boron-containing Compounds Drug Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 68. India Boron-containing Compounds Drug Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Boron-containing Compounds Drug Sales YoY (2020-2031) & (Units)
Figure 70. Central and South America Boron-containing Compounds Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Boron-containing Compounds Drug Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Boron-containing Compounds Drug Sales Volume (Units) by Type (2021-2031)
Figure 73. Central and South America Boron-containing Compounds Drug Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Boron-containing Compounds Drug Sales Volume (Units) by Application (2020-2031)
Figure 75. Central and South America Boron-containing Compounds Drug Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Boron-containing Compounds Drug Sales YoY (2020-2031) & (Units)
Figure 79. Middle East and Africa Boron-containing Compounds Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Boron-containing Compounds Drug Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Boron-containing Compounds Drug Sales Volume (Units) by Type (2021-2031)
Figure 82. South America Boron-containing Compounds Drug Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Boron-containing Compounds Drug Sales Volume (Units) by Application (2020-2031)
Figure 84. Middle East and Africa Boron-containing Compounds Drug Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Boron-containing Compounds Drug Revenue (2020-2025) & (US$ Million)
Figure 89. Boron-containing Compounds Drug Industry Chain Mapping
Figure 90. Regional Boron-containing Compounds Drug Manufacturing Base Distribution (%)
Figure 91. Global Boron-containing Compounds Drug Production Market Share by Region (2020-2031)
Figure 92. Boron-containing Compounds Drug Production Process
Figure 93. Regional Boron-containing Compounds Drug Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
